Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Osteoporosis: HELP
Elizabeth Rosenberg
Based on 10 articles published since 2009
(Why 10 articles?)
||||
Expertise Level
The expertise of Elizabeth Rosenberg ranks in the
  • Top 1.6%
  • ... of 58,015 published authors worldwide on Osteoporosis
  • ... from 2009 through 2019
  • ... based on contributions to 10 articles on the topic.
Graphical view (beta)
Aliases Rosenberg, E   ·   Rosenberg, Elizabeth
Work Locations
Details
Most likely:    Merck and Co      
2016
  • Helen Hayes Hospital, West Haverstraw, NY, USA. · Department of Medicine, Columbia University, New York, NY, USA. · CGM Research Trust, The Princess Margaret Hospital Christchurch, Christchurch, New Zealand. · Oregon Osteoporosis Center, Portland, OR, USA. · Department of Orthopaedics, Hadassah Hebrew University Hospital, Jerusalem, Israel. · Mediclinic Panorama, Cape Town, South Africa. · Department of Obstetrics and Gynaecology, Faculty of Health, Sciences, Stellenbosch University, Stellenbosch, South Africa. · Merck & Co, Inc., Kenilworth, NJ, USA. · Pubmed 26556736
2014
  • Osteoporoseklinikken (J.H.), 0176 Oslo, Norway · Osteoporosis Prevention and Treatment Center (S.G.), Division of Geriatric Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213 · Clinical Research Center (F.C.), Helen Hayes Hospital, West Haverstraw, and Department of Medicine, Columbia University, New York, New York 10027 · Helderberg (G.E.), Clinical Trials Centre, South Africa 7129 · and Merck & Co Inc (A.S., A.L., N.H., S.S., S.D., E.R., A.E.D.), Whitehouse Station, New Jersey 08889. · Pubmed 25166719
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Elizabeth Rosenberg in 2009-2019 about Osteoporosis:

  • A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates. 2016
  • A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis. 2014
  • Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosis. 2014
  • Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis--a double-blind, randomized, dose-finding study. 2014
  • BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate. 2013
  • Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial. 2013
  • Inhibition of cathepsin K for treatment of osteoporosis. 2012
  • Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency. 2011
  • Response to oral bisphosphonates in subgroups of younger and older postmenopausal women. 2010
  • Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates. 2009
Show List of Full Article Records
Google Searches

Learn more about Elizabeth Rosenberg using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Merck and Co
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Merck and Co
2016
  • Helen Hayes Hospital, West Haverstraw, NY, USA. · Department of Medicine, Columbia University, New York, NY, USA. · CGM Research Trust, The Princess Margaret Hospital Christchurch, Christchurch, New Zealand. · Oregon Osteoporosis Center, Portland, OR, USA. · Department of Orthopaedics, Hadassah Hebrew University Hospital, Jerusalem, Israel. · Mediclinic Panorama, Cape Town, South Africa. · Department of Obstetrics and Gynaecology, Faculty of Health, Sciences, Stellenbosch University, Stellenbosch, South Africa. · Merck & Co, Inc., Kenilworth, NJ, USA. · Pubmed 26556736
2014
  • Osteoporoseklinikken (J.H.), 0176 Oslo, Norway · Osteoporosis Prevention and Treatment Center (S.G.), Division of Geriatric Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213 · Clinical Research Center (F.C.), Helen Hayes Hospital, West Haverstraw, and Department of Medicine, Columbia University, New York, New York 10027 · Helderberg (G.E.), Clinical Trials Centre, South Africa 7129 · and Merck & Co Inc (A.S., A.L., N.H., S.S., S.D., E.R., A.E.D.), Whitehouse Station, New Jersey 08889. · Pubmed 25166719
9 Other Locations Show
Yearly article counts 00010321111
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.